- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/415 - 1,2-Diazoles
Patent holdings for IPC class A61K 31/415
Total number of patents in this class: 4045
10-year publication summary
|
226
|
208
|
231
|
188
|
212
|
201
|
195
|
159
|
209
|
199
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Merck Sharp & Dohme Corp. | 2190 |
58 |
| The Regents of the University of California | 20245 |
54 |
| Bristol-myers Squibb Company | 4833 |
44 |
| Novartis AG | 10635 |
42 |
| Theravance Biopharma R&D IP, LLC | 453 |
39 |
| Allergan, Inc. | 2315 |
33 |
| Arena Pharmaceuticals, Inc. | 359 |
33 |
| Vanderbilt University | 1931 |
30 |
| Merck Sharp & Dohme LLC | 3735 |
29 |
| Laboratorios Del Dr. Esteve, S.A. | 163 |
28 |
| University of Southern California | 2122 |
24 |
| Boehringer Ingelheim International GmbH | 4644 |
23 |
| Janssen Pharmaceutica N.V. | 3351 |
23 |
| Takeda Pharmaceutical Company Limited | 2719 |
23 |
| Epizyme, Inc. | 374 |
23 |
| Glaxosmithkline LLC | 535 |
22 |
| Warsaw Orthopedic, Inc. | 3000 |
20 |
| Inflazome Limited | 85 |
20 |
| AstraZeneca AB | 2854 |
19 |
| F. Hoffmann-La Roche AG | 7931 |
18 |
| Other owners | 3440 |